Bank of Nova Scotia trimmed its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 14.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 30,701 shares of the company’s stock after selling 5,009 shares during the period. Bank of Nova Scotia’s holdings in HCA Healthcare were worth $3,149,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Smithfield Trust Co. lifted its position in shares of HCA Healthcare by 541.9% during the 2nd quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock valued at $102,000 after acquiring an additional 840 shares during the period. Summit Trail Advisors LLC increased its stake in shares of HCA Healthcare by 9,933.3% during the 1st quarter. Summit Trail Advisors LLC now owns 112,774 shares of the company’s stock worth $113,000 after purchasing an additional 111,650 shares in the last quarter. Signet Financial Management LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $137,000. Adviser Investments LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $159,000. Finally, Bridgeworth LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $173,000. Institutional investors own 70.37% of the company’s stock.

In other news, SVP Jane D. Englebright sold 6,543 shares of the business’s stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $129.86, for a total transaction of $849,673.98. Following the completion of the sale, the senior vice president now directly owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 1,689 shares of the business’s stock in a transaction on Wednesday, July 25th. The shares were sold at an average price of $112.53, for a total transaction of $190,063.17. Following the sale, the senior vice president now directly owns 10,057 shares of the company’s stock, valued at $1,131,714.21. The disclosure for this sale can be found here. Insiders sold a total of 170,257 shares of company stock valued at $21,118,053 over the last ninety days. 2.80% of the stock is owned by corporate insiders.

A number of brokerages have recently weighed in on HCA. Jefferies Financial Group raised their price objective on shares of HCA Healthcare to $155.00 and gave the stock a “buy” rating in a research note on Friday. Robert W. Baird raised their price objective on shares of HCA Healthcare from $130.00 to $150.00 and gave the stock a “positive” rating in a research note on Thursday, September 20th. Bank of America raised their price objective on shares of HCA Healthcare from $125.00 to $135.00 and gave the stock an “underperform” rating in a research note on Tuesday, September 18th. Royal Bank of Canada raised their price objective on shares of HCA Healthcare to $150.00 and gave the stock an “outperform” rating in a research note on Monday, September 10th. Finally, Argus raised their price objective on shares of HCA Healthcare to $150.00 and gave the stock a “buy” rating in a research note on Friday, September 7th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have issued a buy rating to the company. HCA Healthcare currently has a consensus rating of “Buy” and an average price target of $131.62.

HCA stock opened at $134.31 on Tuesday. The company has a market capitalization of $46.15 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.18 and a beta of 0.53. The company has a debt-to-equity ratio of -7.64, a current ratio of 1.36 and a quick ratio of 1.15. HCA Healthcare Inc has a one year low of $71.18 and a one year high of $138.18.

HCA Healthcare (NYSE:HCA) last released its earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.16 by $0.13. The firm had revenue of $11.53 billion during the quarter, compared to analysts’ expectations of $11.32 billion. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. HCA Healthcare’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.73 EPS. sell-side analysts expect that HCA Healthcare Inc will post 9.23 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 28th. Shareholders of record on Tuesday, September 4th will be paid a $0.35 dividend. The ex-dividend date is Friday, August 31st. This represents a $1.40 annualized dividend and a yield of 1.04%. HCA Healthcare’s payout ratio is currently 21.24%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: What is a Call Option?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.